Clene Inc. (CLNN)
NASDAQ · Manufacturing · Pharmaceutical preparations
$4.30+$0.0900 (+2.14%) on the dayAs of the close; data may be delayed.
CLNN price, last 12 months
Key stats
- Previous close
- $4.21
- Open
- $4.15
- Day range
- $4.12 – $4.49
- 52-week range
- $3.25 – $13.50
- Volume
- 136.5K
- Avg volume (20 days)
- 149.9K
- Market cap
- $61.1M
Performance
1W−1.2%
1M−7.5%
3M−29.0%
6M−20.2%
YTD−26.8%
1Y−28.9%
vs S&P 500, 1Y−45.7 pts
Technicals and fundamentals
About Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $61.1M